Rep. Jim McGovern is New Co-Chair of Congressional Cystic Fibrosis Caucus

After more than six years of dedicated service as co-chair of the Congressional Cystic Fibrosis Caucus, Rep. Edward Markey (D-MA) has stepped down from the post as he assumes new responsibilities in the U.S. Senate. Rep. Jim McGovern (D-MA) will replace Markey, joining Rep. Tom Marino (R-PA) as co-chair of the Caucus.

| 2 min read
Rep. Jim McGovern poses with advocate.
Rep. Jim McGovern (D-Mass) stops to take a photo with CF Foundation advocate Christine McCarthy.

McGovern is a steadfast champion for the cystic fibrosis community and an active supporter of policies that benefit those with CF. The Congressional Cystic Fibrosis Caucus aims to raise greater awareness about CF in the House of Representatives, while finding ways to improve quality of life and life expectancy for those with the disease.

“I give my sincerest thanks to Sen. Markey for his diligent work on behalf of all those affected by CF, and look forward to continuing this successful partnership as he begins his service in the Senate,” said Robert J. Beall, Ph.D., CF Foundation president and CEO. “I am confident in the abilities of Reps. McGovern and Marino to lead efforts that will make a real difference in the lives of people with cystic fibrosis.”

The Congressional CF Caucus has over 120 bipartisan members from 36 states and the District of Columbia and continues to grow thanks to the dedicated advocacy of Foundation volunteers. It is one of the largest caucuses in Congress.

Share this article
About the CF Foundation | Public Policy | Advocacy
Recent news
CF Foundation Awards Advance Improvements in CF Newborn Screening
News | 4 min read
Cystic Fibrosis Foundation Awards 2023 Impact Grants
News | 5 min read
Adult with CF Provides Testimony at Congressional Hearing on the Impact of Antimicrobial Resistance 
News | 3 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.